Although grants are a nice source of funding for demonstration projects and research, only a for-profit approach that attracts broader investment will ensure that this scheme catches on. The funder makes a deal with whoever is responsible for the health-care costs: upfront investment in exchange for continued payment of the $1 billion yearly baseline, with the funder to keep the future savings against originally predicted costs.